UK API Market

UK API Market Size, Share & Trends Analysis Report, By Type (Generic API and Branded API), By Type of Synthesis (Biotech API, Synthetic API, and Other API), By Therapeutics (CVD Drugs, Oncology Drugs, Neurology Drugs, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), and Others), and Forecast 2019-2025.
    Update Available - Forecast 2024-2030   

Published: Feb 2020 | Report Code: OMR2021167 | Category : Pharmaceuticals | Delivery Format: /

UK API market is estimated to witness a growth rate of around 6.0% over the period of 2019–2025. UK has a significant market for API in Europe in 2018. The country invests more in R&D in pharmaceutical industry than any other industry. As per the Association of British Pharmaceutical Industry, UK spent around 33.2% of total R&D expenditure on the pharmaceutical industry in 2016. Private companies spending more than the government on research; public-private investment also plays an important role in market growth of API in the country. Moreover, an increase in the production capacity of drug manufacturers for fulfilling the demands for innovative drugs to handle epidemic and influenza is increasing the demand for the outsourcing pharmaceutical services, which in turn, enhances the growth of the API market.

Visit for Global API Market Report at: https://www.omrglobal.com/industry-reports/api-market

UK API market is segmented on the basis of type, type of synthesis, manufacturer type, therapeutics, and region. On the basis of type, the market is divided into a generic API and branded API. The branded API segment is estimated to be the dominant segment over the forecast period. On the basis of the type of synthesis, the market is classified into biotech API, synthetic API, and others. The synthetic API segment held the dominant position in UK API market. Furthermore, the market is classified on the basis of therapeutics into cardiovascular drugs, oncology drugs, neurology drugs, Non-steroidal Anti-inflammatory Drugs (NSAIDs), and others. NSAIDs therapeutics segment held the leading position in 2018.

Some of the prominent players that contribute significantly in the market include Teva Pharmaceutical Industries Ltd., Sanofi SA, Novartis International AG, Boehringer Ingelheim International GmbH, and others. Further, companies such as AbbVie, Inc., AstraZeneca, PLC, GlaxoSmithKline, PLC, and Mylan N.V., is committed to developing innovative cost-effective vaccines, which will also contribute to the growth of the market. Increasing demand for personalized treatments, the rise of new manufacturing technologies, and the trend of digital medicines are some of the primary growth factors for the pharmaceutical industry growth in UK.

Research Methodology

The market study of the UK API market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

  • Financial reports of companies involved in the market.
  • Authenticate databases such as the American Heart Association, the National Institute of Health, and the International Diabetes Federation.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for pharmaceutical and biotechnology companies, healthcare organizations, research institutes and academic institutes, pharmaceutical drug manufacturers, API manufacturers, raw material suppliers, distributors, traders, government organizations and regulatory agencies, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, different products, and future market opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation

  1. UK API Market Research and Analysis by Type
  2. UK API Market Research and Analysis by Type of Synthesis
  3. UK API Market Research and Analysis by Therapeutics

The Report Covers

  • Comprehensive research methodology of UK API market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting UK API market.
  • Insights about market determinants that are stimulating UK API market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players. 

1. Report Summary

1.1. Research Methods and Tools

1.2. Market Breakdown

1.2.1. By Segments

2. Market Overview and Insights

2.1. Scope of the Report

2.2. Analyst Insight & Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

2.3. Rules & Regulations

3. Competitive Landscape

3.1. Company Share Analysis

3.2. Key Strategy Analysis

3.3. Key Company Analysis

3.3.1. Overview

3.3.2. Financial Analysis

3.3.3. SWOT Analysis

3.3.4. Recent Developments

4. Market Determinants 

4.1. Motivators

4.2. Restraints

4.3. Opportunities 

5. Market Segmentation

5.1. UK API Market by Type

5.1.1. General API

5.1.2. Branded API

5.2. UK API Market by Type of Synthesis

5.2.1. Biotech API

5.2.2. Synthetic API

5.2.3. Others (High Potency API)

5.3. UK API Market by Therapeutics

5.3.1. Cardiovascular Drugs

5.3.2. Oncology Drugs

5.3.3. Neurology Drugs

5.3.4. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

5.3.5. Others (Orthopedic Drugs)

6. Company Profiles

6.1. Aesica Pharmaceuticals, Ltd.

6.2. Almac group PLC

6.3. AstraZeneca PLC

6.4. Boehringer Ingelheim International GmbH

6.5. CordenPharma GmbH

6.6. Fareva SA

6.7. GlaxoSmithKline PLC

6.8. Novartis International AG

6.9. Saneca Pharmaceutical AS

6.10. Sanofi SA

6.11. Siegfried Holding AG

6.12. Teva Pharmaceutical Industries Ltd

1. UK API MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)

2. UK API MARKET RESEARCH AND ANALYSIS BY TYPE OF SYNTHESIS, 2018-2025 ($ MILLION) 

3. UK API MARKET RESEARCH AND ANALYSIS BY THERAPEUTICS, 2018-2025 ($ MILLION) 

1. UK API MARKET SHARE BY TYPE, 2018 VS 2025 (%)

2. UK API MARKET SHARE BY TYPE OF SYNTHESIS, 2018 VS 2025 (%)

3. UK API MARKET SHARE BY THERAPEUTICS, 2018 VS 2025 (%)